Constipation 2 - Pharmacology Flashcards

1
Q

Treatment of Constipation

A

•Usually effectively treated with dietary modification (increasing fibre, hydration, exercise)

•Only if this fails should laxatives be used.
Therapy Classes:
1. Bulk-forming laxatives
2. Osmotic laxatives
3. Stimulant laxatives
4. Stool softeners
5. Other agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Bulk-forming laxatives
A

increase volume of matter in GI tract

bulk forming laxative - increases volume of substance in colon by doing that they activate stretch receptor and tactile receptor in wall of colon and that acts to increase colonic activity and peristalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Osmotic laxatives
A

increase the volume of liquid in GI tract

has a dual purpose - by increasing fluid content it makes the stools softer and by increasing volume in the colon it activates stretch receptors and the tactile receptors then increases activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Stimulant laxatives
A

increase activity of colon

direct stimulants increase activity of muscles in the colon wall and increase peristalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Stool softeners
A

act to allow the colon to do its job more efficiently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Other agents
A

viewed as separate due to their mechanism of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Laxatives: Broad Mechanisms of Action

A
  • fibre increases bulk of stools
  • faecal softener lubricates the stool
  • stimulant increases peristalsis
  • stimulant increases peristalsis
  • osmotic laxative increases fluid content of stool
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

General Contraindications to Use

A
  • Broadly, laxatives should not be used in the presence of undiagnosed abdominal pain
  • The danger is that the drugs may cause an inflamed organ (eg, the appendix) to rupture and spill GI contents into the abdominal cavity with subsequent peritonitis, a life-threatening condition.
  • Oral drugs also are contraindicated when a diagnosed GI disturbance is likely to be worsened by increased motility (e.g. with intestinal obstruction and fecal impaction or inflammatory bowel diseases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bulk Laxatives

A
  • Insoluble Non digestible and non-absorbable (pass into the colon whole and unaffected)
  • Increase in bowel content volume triggers stretch receptors in the intestinal wall
  • Causes reflex contraction (peristalsis) that propels the bowel content forward
  • May take several days – 2 weeks to have full effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classes of Bulk Laxatives

A
  • Isphagula (Psyllium)
  • Methylcellulose
  • Sterculia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bulk laxatives

• ADR’s

A

– Bloating and flatulence; GI obstruction & impaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bulk laxatives

• Cautions

A

– Adequate fluid intake should be maintained to avoid obstruction
• May need management in elderly & debilitated patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bulk laxatives

• Contraindications

A
  • Colonic atony – colon will not be stimulated by activation of stretch receptors
  • Faecal impaction & intestinal obstruction – increased motility will not lead to defecation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atony definition

A

muscles in colon are not activated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Osmotic Laxatives

A

-work more rapidly than bulk forming laxative
• Effective in 1-3 hours
• Used to purge intestine (e.g. prior to surgery, poisoning)
• Fluid is drawn into or retained in the bowel by osmotic force, increasing volume and triggering peristalsis (makes stools wetter and softer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Osmotic Laxatives classes

A

• Nondigestible sugars and alcohols
- Lactulose (broken down by bacteria to acetic
and lactic acid, which causes the osmotic effect)
• Macrogol 3350– polymer of ethylene glycol (acts to retain water in colon)
• Salts
• Magnesium hydroxide (Mg(OH)2) (Milk of Magnesia)
• Sodium Phosphates (used as enema)
• (Epsom Salt (MgSO4)) - very strong and causes very rapid evacuation of colon - not recommended anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Two main issues associated with osmotic laxatives

A

– Increased GI activity

– Electrolyte & osmotic imbalances (in danger of dehydration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Osmotic Laxatives

• ADR’s

A

–abdominal discomfort; diarrhoea

19
Q

Osmotic Laxatives

• Cautions

A

– Broadly those at danger of dehydration (elderly, debilitated); and those at risk of electrolyte imbalance (cardiac diseases)

20
Q

Osmotic Laxatives

Contraindications

A

Acute GI conditions; intestinal obstruction & inflammation

21
Q

Stimulant Laxatives

A
  • Irritate the GI mucosa and Increases intestinal motility
  • Indicated for severe constipation where more rapid effect is required (6-8 hours) or where bulk forming laxatives haven’t had the required effect
22
Q

Stimulant Laxatives classes

A
  • Bisacodyl
  • Anthraquinones – Co-danthramer, Co-danthrusate, Senna
  • (Cascara, Castor Oil - From the Castor Bean – obsolete) NOT RECOMMENDED
23
Q

Pharmacology of Stimulant Laxatives

A

draw chart

Galenic form

  • Bisacodyl -> activated by colonic hydrolases -> activated by bis-(p-hydroxyphenyl)-pyridyl-2-methane
  • Sodium picosulfate -> activated by colonic flora -> activated by bis-(p-hydroxyphenyl)-pyridyl-2-methane
  • Senna -> activated by colonic flora -> activated by rhein anthrone
24
Q

Pharmacology of Stimulant Laxatives - what is galenic form

A

is the formulated form which patients take the medicine in

25
Q

Pharmacology of Stimulant Laxatives: bisacodyl

A

has to be formulated so it reaches the colon before the active ingredient becomes available

26
Q

Pharmacology of Stimulant Laxatives: sodium picosulfate

A

almost a pro drug of bisacodyl

27
Q

Pharmacology of Stimulant Laxatives: colonic hydrolases

A

in the gut wall

28
Q

Pharmacology of Stimulant Laxatives: colonic flora

A

only bacteria found in the colon

29
Q

Pharmacology of Stimulant Laxatives: bis-(p-hydroxyphenyl)-pyridyl-2-methane

A

irritates and activates wall of GI tract

30
Q

Stimulant Laxatives

- main issues

A

• Do what they say on the tin…
– ADR’s, cautions & contraindications similar to osmotic laxatives

Two main issues
– Increased GI activity
– Electrolyte & osmotic imbalances

31
Q

Stimulant Laxatives

• Cautions

A

– Those at risk of dehydration or hypokalaemia

32
Q

Stimulant Laxatives

• CI’s

A

– Inflamed & obstructed intestines; undiagnosed abdominal pain

33
Q

Co-danthrusate and Co- danthramer

A

-very effective laxative
• Evidence of carcinogenicity & genotoxicity in animal studies
• Use limited to patients with terminal illnesses

34
Q

genotoxicity

A

destructive effect on a cell’s genetic material (DNA, RNA) affecting its integrity.

35
Q

carcinogenicity

A

Ability of a carcinogen to produce invasive cancer cells from normal cells.

36
Q

Stool Softners - Emollients (types)

A

• Docusate sodium (surfactant and stimulant) main one used
• Arachis oil (enema) help with fecal impaction
- Peanut oil (allergies)
• Liquid Paraffin (oral solution)
- Extemporaneous preparation

37
Q

Docusate sodium

A

Surfactant and bulking agent (stimulates wall of GI tract)
• Oral: up to 500mg daily in divided doses
– Acts within 1-2 days
• Rectal (enema): 120 mg for 1 dose
– Acts within 20 minutes
• ADRs: Abdominal pain, diarrhoea; hypokalaemia
• Cautions: Patients where hypokalaemia to be avoided; Rectal preparation not indicated with haemorrhoids
• Contraindications :Intestinal blockage

38
Q

Opioid Antagonists for Opioid-Induced constipation - draw diagram and explain

A

draw diagram

  • Endogenous opioids act at opioid receptors in brain and periphery.
  • In the brain activation of central u opioid receptors can provide analgesia (pain relieve).
  • Exogenous opioids such codeine and morphine are used as analgesics for patients in palliative care or patients with cancer.
  • u opioid receptors in GI tract activation leads to changes in muscle tone and sensitivity.
  • Opioid antagonists can be given to block u opioid receptors in GI tract but not all opioid antagonists will be suitable as they may cross the BBB and block action of opioid agonist in the brain aswell.
  • Instead we want Peripheral opioid antagonist to act at gut only and not brain.
39
Q

Methylnaltrexone

A
  • Peripherally acting opioid antagonist
  • Subcutaneous injection; 8-12 mg 4-7 doses/week
  • Tmax: 0.5hr; T1⁄2 8hrs (rapid t max but long half life - leads to well above therapeutic threshold)
  • ADRs: Abdominal pain, diarrhoea; flatulence
  • Cautions: Patients with damaged GI tract
  • Contraindications:Acute surgical abdominal conditions; Intestinal blockage
40
Q

Prucalopride

A
  • Selective 5HT-4 agonist with prokinetic properties (increase activity, decrease GI transit time)
  • 2mg once daily, review after 4 weeks
  • ADRs - wide range of abdominal side effects associated with action
  • Cautions – arrythmias & ischaemic heart disease (hERG) affects QT interval
  • Contraindications – Crohn’s disease, abdominal obstruction and other serious GI conditions
41
Q

Lubiprostone (trade name - Amitiza)

A
  • Chloride channel blocker – acts locally to increase fluid secretion and motility
  • 24 μg (micrograms) twice daily for 2-4 weeks
  • PK – low oral bioavailability – actions in GI tract (limits the ADR to abdominal ADRs)
  • ADR’s – wide range of abdominal side effects associated with action
  • Contraindications – GI obstruction
42
Q

• ALWAYS bear in mind potential for damage

A

– when a diagnosed GI disturbance is likely to be worsened by increased motility
– When undiagnosed abdominal pain is present

43
Q

What does peripheral opioid antagonist do?

A

Peripheral opioid antagonist dislodges opioid from u-opioid receptors in GI tact and this leads to reduction in adverse gastrointestinal effects of exogenous opioid analgesics